長期作用の注射用剤として使用するための高濃度ベダキリンサスペンションの開発
Mads Fahnøe Hansen1, Nadina Zulbeari1, René Holm1
1Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark.
International journal of pharmaceutics
|August 24, 2025
まとめ
この研究では,結核の治療のために長時間作用するベダキリンフーマレートの注射製剤が開発されました. この新薬は3ヶ月の治療期間を可能にし,アデバーンスを改善し,薬剤耐性を予防します.
科学分野:
- 医薬品科学
- 薬物投与システム
- 感染症
背景:
- 結核 (TB) は世界的な健康問題であり,患者さんの不十分な服従と薬剤耐性菌株の増加により悪化しています.
- 現在行われている結核治療は 長期的で 厳しいもので 最適でない結果と 耐性の出現に寄与しています
- 長期作用の注射薬 (LAI) は,治療の順守と有効性を改善する潜在的戦略を提供します.
研究 の 目的:
- ベダキリンフーマレートの高濃度,長時間作用の注射用 (LAI) 製剤の製造の可能性を調査する.
- LAIベダキリンフーマレート製剤の物理的安定性,薬剤負荷能力,および薬理学的特性を評価する.
- このLAI製剤の潜在力を評価し,TBの新たな長期的な治療戦略として,薬剤耐性を予防する.
主な方法:
- ベダキリンフーマレートのマイクロおよびナノサスペンションは,湿った介質の磨きで製造された.
- 製剤は安定剤の適性,薬物の負荷能力,および6ヶ月間の粒子の大きさの安定性について評価された.
- 異なる粒径の成分の筋肉内注射後に,スプラグ・ダウリーマウスを用いて,薬理学的な研究が行われました.
主要な成果:
- ベダキリン・フーマレート塩は,自由塩基と比較して薬物の負荷能力が優れていることが示され,流動性のある液体の濃度が高いことが認められた.
- 粒子の大きさは,より小さな粒子がより高い血濃度をもたらすことで,初期薬剤の放出運動に大きく影響した.
- 試験されたすべてのLAI製剤は,ラットで3ヶ月間にわたってプラズマ濃度が延長され,より長期的な効果の可能性を示唆しました.
結論:
- LAIベダキリンフーマレート製剤の開発は3ヶ月の結核治療期間で可能であり,さらに長い有効性を持つ可能性があります.
- LAIサスペンションで高い薬物負荷を達成するために,フーマレート塩の形態は有利です.
- これらの有望なLAI製剤の物理的安定性を最適化するためにさらなる研究が必要である.
関連する概念動画
Factors Influencing Drug Absorption: Pharmaceutical Parameters
192
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
192
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.0K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.0K
Biopharmaceutics and Pharmacokinetics: Overview
2.5K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.5K
Factors Influencing Drug Absorption: Drug Dissolution
701
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
701
Routes of Drug Administration: Parenteral
2.1K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.1K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
403
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
403


